Ken Fisher's position in Catalyst Pharmaceuticals is currently worth $1.71 Million. That's 0.00% of their equity portfolio (605th largest holding). The first Catalyst Pharmaceuticals trade was made in Q3 2021. Since then Ken Fisher bought shares two more times and sold shares on three occasions. The stake costed the investor $659 Thousand, netting the investor a gain of 160% so far.